Skip to main navigation Skip to search Skip to main content

Fertility preservation in females with malignant disease-1: Causes, clinical needs and indications

Research output: Contribution to journalReview articlepeer-review

Abstract

Cancer incidence is progressively increasing in parallel with an increase in the rate of cancer survivors with the help of advanced treatment modalities. By the year 2010, it is estimated that one in every 250 persons will have survived a childhood malignancy. The increased rates of survival bring about complications related to reproductive health. Cytotoxic treatments due to chemo- and radiotherapy or bone marrow transplantation suppress or irreversibly harm not only female ovarian reserve but also male testicular sperm production. In this review, cryopreservation of gametes and gonads with fertility preservation options and indications prior to cancer treatments are discussed.

Original languageEnglish
Pages (from-to)106-113
Number of pages8
JournalTurkish Journal of Hematology
Volume26
Issue number3
Publication statusPublished - 5 Sept 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cancer
  • Chemotherapy
  • Cryopreservation
  • Fertility preservation
  • Radiotherapy

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Fertility preservation in females with malignant disease-1: Causes, clinical needs and indications'. Together they form a unique fingerprint.

Cite this